Introduction
Cystic fibrosis (CF) is a fatal autosomal recessive disease affecting around one in 2500 Caucasians. 1 The disorder is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene 2 which encodes a cAMP/PKA activated Cl − channel located on the apical surface of epithelial cells. 3, 4 CFTR can regulate several other ion channels including ENaC, an epithelial sodium channel. 5 Loss of CFTR function affects a variety of organs most notably the airways, intestinal tract, pancreas, sweat glands and reproductive system. One hypothesis is that ion imbalances in epithelial cell secretions lead to an accumulation of viscous mucus which initiates most of the pathology associated with CF. In the lung, mucus accumulation promotes recurrent microbial infections and subsequent inflammatory reactions, which destroy the tissue and are responsible for the majority of CF morbidity and mortality.
It is hoped that delivery of a normal CFTR gene to the airway epithelium will correct the underlying genetic defect and provide a supplementary treatment to current therapies. Delivery of the CFTR gene to human CF airway epithelial cells in vitro results in restoration of Cl − channel activity [6] [7] [8] and this has also been demonstrated in vivo [9] [10] [11] [12] following liposome-mediated gene delivery to the airways of CF mice. 13, 14 Clinical trials have also been performed using liposomal [15] [16] [17] [18] or adenoviral [19] [20] [21] deliv-that retains the in vivo cellular architecture. We have demonstrated correction of CFTR-dependent Cl − secretion following ex vivo delivery of the CFTR gene to tracheas from CF null mice. We have used this system to examine parameters affecting liposome-mediated gene delivery to the upper airway such as plasmid dose. We have also found that a contact time of 1 min for the transfection mixture is sufficient to achieve significant DNA binding and maximal reporter gene expression. Gene Therapy (2000) 7, 612-618.
ery vehicles to the nasal and bronchial epithelium as a surrogate target tissue for the lung. These vectors show similar low efficiencies of gene delivery in patients 22 and CFTR expression is short-lived, lasting only 1-2 weeks.
Gene transfer experiments using cultured cell lines underestimated the difficulty of gene delivery to the airway epithelium. 23, 24 The discrepancy between in vitro and in vivo gene transfer efficiency creates a need for a model system which accurately reflects the difficulties of delivery to the airway epithelium in vivo. Model systems that have been developed include human nasal epithelial multicellular spheroids, 25 human nasal epithelial brushings, the generation of human airway xenografts in rats or immunodeficient mice 26, 27 and culture of sheep tracheal explants. 28 We have developed a simple, tracheal culture system and used this to test parameters affecting transfection efficiency which cannot be readily assessed in vivo. We have validated this model with respect to maintenance of normal tissue integrity and electrophysiological profiles. We have also demonstrated liposome-mediated reporter gene and CFTR delivery in this system and have begun to establish important parameters affecting gene delivery to the airway epithelium. This system could be used to evaluate the toxicity of transfection components over extended contact times.
Results
Tracheal explants retain normal histological appearance after overnight culture Tracheas were maintained in culture for 24 h and their integrity determined by sectioning. The gross mor- Electrophysiological responses are maintained after culture To confirm full tissue integrity, physiological tests were performed to determine the viability of the tracheas after ex vivo culture for 24 h. The electrical resistance across the tracheal epithelium was determined by measuring changes in short circuit current (SCC) following an increase in the voltage at which the tissue was clamped. There was no significant difference (P = 0.24; two-tailed Mann-Whitney) between the mean resistance of freshly dissected tracheas (22.9 ± 2.2 ⍀cm 2 , n = 10) and those maintained ex vivo (17.7 ± 3.8 ⍀cm 2 , n = 8). These transepithelial resistance values are similar to those reported in murine tracheal epithelia by Grubb et al. 29 As a final test of tissue integrity and cell function, the electrophysiological profiles of fresh and cultured trachea in response to pharmacological agents were compared (Table 1 and Figure 2 ). Changes in SCC reflect the activity of ion channels in the tracheal epithelium and we have previously characterized these responses in the murine trachea. 13, 30 Amiloride reduced the basal SCC by blocking sodium absorption while forskolin caused an increase in SCC which was blocked by the addition of frusemide, an inhibitor of the basolateral Na
− co-transporter, showing it to be the result of Cl − secretion. The basal SCC and the amiloride responses were significantly different after ex vivo culture most likely due to increased Na + absorption caused by the dexamethasone in the culture media. In contrast, no significant differences in responses to forskolin or frusemide were seen between cultured and fresh trachea (Table 1 and Figure 2a and b).
Ex vivo tracheal transfection with a luciferase reporter gene To determine whether liposome-mediated gene delivery could be achieved in the ex vivo trachea, a luciferase reporter plasmid pCMVluc (pVR1223) complexed with the liposome DC-Chol/DOPE was used. Following transfection, the tracheal epithelium was harvested by scraping into reporter lysis buffer and the remaining carcass homogenized into lysis buffer. The majority of luciferase activity was found in the epithelial cell lysate (61.4 ± 3.2%; n = 32) consistent with the epithelial cells lining the tracheal lumen representing the main transfected cell population. All ex vivo luciferase activities described are those found in the epithelial sample.
Tracheas from CF mice can be distinguished from wildtype tissue after culture Having shown that reporter gene expression can be achieved in this system, we wished to determine whether a more physiologically relevant gene could also be delivered. We chose to use CFTR because of the existence of a null CF mouse model (Cftr tm1Cam ). 13 To detect CFTR gene expression we first confirmed that we could distinguish CF and wild-type tracheas after culture for 24 h. The forskolin response in tracheas from wild-type mice ( Figure  3a ) was significantly higher (P Ͻ 0.05) than in CF null mice (Figure 3b ), while the responses to all other drugs were not significantly different (Table 2) , although there was a trend to increased basal current and amiloride inhi- bition in some groups. We can therefore distinguish the tracheas of the mice on the basis of their genotype.
Ex vivo tracheal transfection with the CFTR gene restores Cl
− channel activity The plasmid pT10-CFTR2, carrying the CFTR cDNA, or the control plasmid pT10 with no CFTR gene, were delivered with DC-Chol/DOPE into ex vivo trachea from CF null mice and changes in SCC responses measured 24 h later. A 10 g dose of pT10-CFTR2 has previously been shown to restore Cl − channel activity following intra-tracheal delivery in vivo. 9 Transfection with pT10-CFTR2 resulted in restoration of the forskolin response to wildtype levels with no significant effect on any other responses ( Figure 3d and Table 2 ). The responses of the null tracheas treated with pT10 to forskolin and the other pharmacological agents did not differ significantly from those in untreated null tracheas ( Figure 3c and Table 2 ).
Dose-response of gene transfection ex vivo
We wished to use this model to investigate parameters affecting airway gene delivery. To determine the lowest dose of pCMVluc:DC-Chol/DOPE lipoplex that could give a consistent luciferase gene signal, a dose-response study was performed. A direct relationship was observed between plasmid dose and luciferase activity with as little as 10 ng of plasmid generating a signal (0.26 ± 0.06 RLU/g protein; n = 6) significantly above background (0.01 ± 0.003 RLU/g, P Ͻ 0.002, Figure 4a ).
The effect of contact time on reporter gene expression and DNA binding The tracheal culture system was used to examine the effect of contact time on gene transfer efficiency. We wished to establish whether a short contact time due to rapid clearance of a transfection mix in vivo was likely to limit gene transfer efficiency. We also wanted to investigate if there was any negative effect of the transfection mix being in contact with the tracheal lumen for extended periods of time. A contact time as short as 1 min gave maximal luciferase expression significantly above background levels (Figure 4b , P Ͻ 0.005, two-tailed MannWhitney). A downward trend in luciferase expression was observed with increasing contact times (Figure 4b ) but this only became significant at the 20 h contact time (P Ͻ 0.002, two-tailed Mann-Whitney) possibly indicating compromised tissue under these conditions.
We were somewhat surprised that maximal gene expression was obtained after a contact time of only 1 min. To study this further, we measured the kinetics of DNA binding to the ex vivo trachea (Figure 4c) . After a 1 min contact time approximately 40% of the radiolabelled DNA had tightly associated with the tracheal epithelia and this increased to 60% after a contact time of 15 min (Figure 4c) . No further increase in binding was observed with longer contact times.
Discussion
We have developed a model for transfection of the upper airway epithelium that provides a tool for developing gene therapy strategies for CF. This model uses culture of the murine trachea and because of the existence of a mouse model of CF, can be used to measure correction of the primary genetic defect in CF. Although bronchiolar 
Figure 4 Evaluation of parameters affecting luciferase reporter gene expression using the ex vivo murine tracheal model. (a) Dose-response curve. Increasing doses of pCMVluc:DC-Chol/DOPE lipoplex at a constant 1:5 (wt:wt) ratio were delivered to the lumen of the tracheas ex vivo and luciferase activity measured 24 h later. Statistically significant differences are indicated (two-tailed, unpaired Mann-Whitney test). Even the lowest dose of pCMVluc (10 ng) gave a signal significantly above the background obtained in untreated trachea or those transfected with a non-luciferase control plasmid containing the lacZ gene (P = 0.004). n = number of samples. (b) Effect of transfection mix contact time. 0.5 g pCMVluc:2.5 g DCChol/DOPE was left in contact with the tracheal lumen for the times indicated and then flushed out with PBS. Luciferase activity was measured 24 h later. A 1 min contact time produced maximal luciferase activity significantly above background (P = 0.001, two-tailed, unpaired Mann-Whitney test). The apparent reduction in luciferase activity at longer contact times compared with the 1 min time-point only became significant after 20 h (P = 0.005, two-tailed, unpaired Mann-Whitney test). (c) Radiolabelled DNA binding assay. 0.5 g radiolabelled DNA and 2.5 g DC-Chol/DOPE were left in contact with the tracheal lumen for the times indicated and then flushed out with PBS. The percentage of radiolabelled DNA bound to the trachea was calculated by dividing the counts obtained from the trachea by the total counts obtained from the trachea and the PBS wash combined. n = number of samples.
epithelial cells will be the eventual target for CF gene therapy, the trachea provides a valid, accessible test system in which relevant electrophysiological correction by CFTR, as well as reporter gene delivery, can be assessed.
The strength of this model lies in being able to control accurately delivery of defined transfection mixtures to a specific target site. We have tested the viability of the tracheal tissue following culture for 24 h. The tracheal epithelium was histologically unchanged and exhibited high trans-epithelial resistance, demonstrating monolayer integrity. The epithelium also showed unchanged SCC responses to a series of pharmacological agents indicating functional integrity. We do not yet know if viability can be extended past 24 h but this culture model provides a method of assessing the early events that might limit gene delivery.
Gene Therapy
The need for an improved model for airway gene delivery arises from the requirement for precise control of experimental variables combined with the gulf between in vitro and in vivo airway gene transfer efficiencies. The observed inefficiency of gene delivery to the airway epithelium in vivo using both liposomes 15, 16, 24 and adenovirus 23 may reflect the lack of appropriate internalization pathways in differentiated epithelial cells. [31] [32] [33] [34] That reporter gene expression levels are relatively low in our ex vivo tracheal model suggests that our system models the difficulties encountered with in vivo gene delivery.
One strength of this model is its use in a system where CFTR gene transfer can be readily monitored by correction of the primary electrophysiological defect of CF. The tracheas of wild-type and null CF mice can be dis-tinguished by SCC analysis. 30 The tracheas of null mice show significantly reduced forskolin induced Cl − secretion and this difference is retained after 24 h in culture. In addition to demonstrating successful reporter gene transfer in this model, we have achieved the more relevant physiological goal of transfecting sufficient epithelial cells with CFTR to correct the electrogenic Cl − secretory defect characteristic of CF epithelia.
Since we are able to measure both CFTR and reporter gene expression following gene delivery ex vivo, this system lends itself to investigating parameters that affect gene transfer efficiency. We have observed a direct correlation between lipoplex dose and reporter gene activity. Although luciferase activity could be detected using as little as 10 ng DNA, the low efficiency of gene transfer in this in vivo-like environment places this amount at the limit of sensitivity. We were unable to detect luciferase protein by immunocytochemistry or to detect ␤-galactosidase or green fluorescent protein activity following transfection although these can all be detected following transfection of cultured epithelial cells (data not shown).
The parameter of lipoplex-target tissue contact time is extremely difficult to control in vivo but could have profound effects on gene transfer efficiency. Our ex vivo model provides an ideal system in which to investigate this and we found that the lipoplex was sufficiently associated with the tracheal epithelium after 1 min, to mediate maximal gene transfer. These data indicate that the initial binding step is very rapid and suggest that binding may not represent a rate limiting step to gene delivery. These results contrast with liposome transfection data in vitro (unpublished observations) and with in vivo adenoviral transfection data 35 and may explain why liposomes have proved no less efficient than adenovirus in clinical trials of CFTR gene delivery to the airways. 22 In summary, we have developed a useful model to validate the next generation of vectors for airway gene delivery that is particularly well suited for demonstrating CFTR gene transfer as a model for CF gene therapy.
Materials and methods

Reagents
Unless stated otherwise all reagents were purchased from Sigma-Aldrich Ltd (Poole, UK) and were of Analar grade or better.
Ex vivo tracheal culture system
Mice were from stocks of the CF null strain, Cftr tm1Cam generated by gene targeting. 13 In experiments using cultured tracheas to study reporter gene transfer, +/+ and +/− animals were used. In experiments requiring electrophysiological measurements, +/+ (wild-type) or −/− (null) animals were used. Mice were killed by CO 2 narcosis and tracheas dissected from above the larynx to the bronchial branch point, and submerged in ice-cold organ culture medium. Within 20 min tracheas were transferred to an organ culture raft (5.0 m pore size membrane; Millipore Ltd, Watford, UK) and maintained at the surface of 4 ml culture medium on a steel mesh support. Initial organ culture conditions were based on the protocols described by Lasnitzki, 36 Ferland and Hugon 37 and Albert et al. 38 Tissues were dissected into Medium 199 with Hank's salts supplemented with 2% newborn calf serum (NCS; TCS Biologicals Ltd, Buckingham, UK) and 8 ng/ml fungizone. The medium soaking the organ culture raft was Dulbecco's modified Eagle's mediumHepes modification supplemented with 10% NCS, 10% NCTC-135, 2 mm l-glutamine, 100 units/ml penicillin and streptomycin, 1 g/ml insulin and 30 ng/ml dexamethasone. The dexamethasone was crucial to maintain tissue viability. Culture dishes were placed within a 9 cm Petri dish with three layers of Whatman 3MM paper (Whatman Ltd, Maidstone, UK) soaked in 10 ml water to maintain humidity. The whole assembly was sealed within a pressure jar (Oxoid Ltd, Basingstoke, UK) filled with medical gas mix (95% O 2 /5% CO 2 ) to 0.5 bar above atmospheric pressure. The jar and contents were incubated at 37°C and the gas mix replenished after 6 and 12 h.
Ex vivo transfections
Tracheas for transfection were dissected into ice-cold organ culture medium and then rinsed in phosphatebuffered saline (PBS). For reporter gene transfections, a plasmid containing the firefly luciferase gene driven by the cytomegalovirus promoter/enhancer was used (pVR1223, 6.6 kb) 39 and DC-Chol/DOPE (3:2 molar ratio of 3␤(N-NЈ,NЈ-dimethyl amino-ethane-carbomoyl) cholesterol:dioleoyl phosphatidyl ethanolamine) were mixed at 1:5 (wt:wt) ratio and made up to a total volume of 5 l with Optimem (Life Technologies Ltd, Paisley, UK) and incubated at room temperature for 15 min. An equivalent plasmid containing the lacZ gene was used for control transfections. The distal end of the trachea was sealed with Indermil surgical adhesive (gift from Dr K Southern, St James's Hospital, Leeds, UK) and 5 l of transfection mix was injected into the tracheal lumen, via the larynx, before this end was also sealed. The tracheas were placed in culture, as described above, for up to 24 h. After a defined contact time the Indermil was removed from the ends and the transfection mix was flushed out with 2 ml PBS. Tracheas were then placed in a fresh organ culture chamber for the remainder of the 24 h period.
For delivery of CFTR cDNA, 10 g pT10-CFTR2 (a 16 kb RSV-promoted plasmid) 30 was mixed with 2 g DCChol/DOPE in a final volume of 12 l and delivered to the tracheal lumen as described above. This 5:1 DNA: liposome ratio has been shown to give good reporter gene delivery ex vivo.
Ex vivo transfection of radiolabelled DNA Radiolabelled DNA was prepared by random oligonucleotide priming using the Multiprime DNA labelling system and ␣-32 P dCTP (Amersham Pharmacia Biotech, St Albans, UK). Unincorporated ␣-32 P dCTP was removed from the reaction using ProbeQuant G-50 Micro Columns (Amersham Pharmacia Biotech). One microlitre of radiolabelled DNA (0.5 g) and 2.5 g DC-Chol/DOPE were mixed and made up to a total volume of 5 l with Optimem. The distal end of the trachea was sealed and 5 l of transfection mix was injected into the tracheal lumen, via the larynx, before this end was also sealed. Where appropriate the tracheas were placed in culture, as described above, for up to 2 h. After a defined contact time the transfection mix was flushed out with 2 ml of PBS. The tracheal carcass and the PBS used to flush the trachea were placed in separate scintillation vials.
Samples were counted using a 1 min Cerenkov counting program.
Reporter gene quantification Tracheas were rinsed in PBS, cut longitudinally and the epithelial cells scraped into 150 l reporter lysis buffer (RLB; Promega, Southampton, UK). The remaining tracheal carcass was manually homogenized in 150 l RLB and both samples freeze-thawed. Cell debris was pelleted at 1300 g for 2 min and the luciferase activity in 20 l of the supernatant was determined using a Turner TD 20/20 Luminometer with a 3 s delay over a 60 s integration. Luciferase activity was standardized to the protein content of each sample which was determined using the BioRad protein assay system (BioRad Laboratories, Hemel Hempstead, UK).
Histology
Paraffin wax sections of tracheas were stained according to a standard protocol with haematoxylin and eosin.
Electrophysiology
Tracheas were dissected to remove the larynx and opened longitudinally by cutting through the centre of the cartilage rings. Each trachea was mounted in an Ussing chamber (window size 2.3 mm 2 ), bathed on both the apical and basolateral surfaces with 20 ml Kreb's Henseleit solution (KHS pH 7.4; 118 mm NaCl, 4.7 mm KCl, 2.5 mm CaCl 2 , 1.2 mm KH 2 PO 4 , 25 mm NaHCO 3 and 11.1 mm glucose) at 37°C and bubbled with 95% O 2 /5% CO 2 . Trans-epithelial potentials were measured, via KHS-filled electrodes with 3 m KCl/1.5% agarose plugs, by calomel cells connected to a WPI DVC-1000 voltage/current clamp (World Precision Instruments Ltd, Stevenage, UK). The short circuit current (SCC) across the epithelium was measured by voltage clamping the tissue at zero potential. Various inhibitors and secretogogues were applied to assess the functional integrity of the tissue 9 and also to detect cAMP mediated Cl − secretion by CFTR. 30 Pharmacological agents were added at the following concentrations and locations: 100 m amiloride apically; 25 m TBHQ (2,5-Di-tert-butyl-hydroquinone), 1 m A23187 and 10 m forskolin (Calbiochem, La Jolla, CA, USA) bilaterally; 1 mm frusemide basolaterally. To determine the trans-epithelial resistance the voltage was clamped at 0.5 mV for a 10 s period every 60 s and the mean change in SCC used to calculate the resistance according to Ohm's Law. Changes in SCC were recorded using a MacLab data acquisition system (ADI Instruments, Castle Hill, NSW, Australia).
